RevitaDERM PSORIASIS
RevitaDERM PSORIASIS is an FDA drug label for the active ingredient COAL TAR manufactured by Blaine Labs Inc. administered by TOPICAL. This page reproduces the FDA-approved indications and usage, dosage, contraindications, warnings, and adverse reactions exactly as published in the drug label. Data source: openFDA (U.S. FDA), label effective 20231221.
Generic: COAL TAR
Manufacturer: Blaine Labs Inc.
Product Type: HUMAN OTC DRUG
Route: TOPICAL
Dosage Form:
NDC: 63347-112
Application: M032
Effective: 20231221
Active Ingredients: Active Ingredients Section Drug Facts Active Ingredient Coal Tar (2%)
Indications & Usage
Uses Section Uses For the relief of symptoms associated with psoriasis and or seborrheic dermatitis including itching, scaling, flaking, redness and irritation of the skin. Helps prevent recurrences. Treats eczema.
Dosage & Administration
Directions Section Directions Apply to affected areas as directed by a doctor. Apply as needed to affected areas as often as needed (up to four times per day)
Contraindications
Not available.
Warnings
Warnings Section Warnings For external use only. Ask a doctor before use For prolonged periods If condition covers a large area of the body Around the rectum or in the genital area or groin With other forms of psoriasis therapy such as ultraviolet radiation or prescription drugs.
Adverse Reactions
Not available.
More from same ingredient
Equate Therapeutic Dandruff Extra Strength Anti-dandruff, anti-seborrheic dermatitis, anti-psoriasis
Wal-Mart Stores, Inc.
Equate Therapeutic Dandruff Original Strength Anti-dandruff, anti-seborrheic dermatitis, anti-psoriasis
Wal-Mart Stores, Inc.
MG217 Psoriasis Medicated Conditioning
Wisconsin Pharmacal Company
MG217 Psoriasis Therapeutic Scalp Treatment
Wisconsin Pharmacal Company